Nova EYE Medical Ltd Cash Flow Conversion Efficiency
Nova EYE Medical Ltd cash flow conversion efficiency. Based on the latest financial reports, Nova EYE Medical Ltd (EYE) has a cash flow conversion efficiency ratio of -0.059x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-846.00K ≈ $-598.60K USD) by net assets (AU$14.28 Million ≈ $10.10 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Nova EYE Medical Ltd (1992–2026)
Cash flow conversion efficiency of Nova EYE Medical Ltd from 1992 to 2026. This chart illustrates how Nova EYE Medical Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Nova EYE Medical Ltd stock quote for real-time trading data and today's change.
Nova EYE Medical Ltd Cash Flow Conversion Ratio Explained
Nova EYE Medical Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Nova EYE Medical Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Nova EYE Medical Ltd ranked by their cash flow conversion efficiency. Also see Nova EYE Medical Ltd stock valuation for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Juic International
TWO:6114
|
0.032x |
|
Microbix Biosystems Inc.
TO:MBX
|
-0.019x |
|
Bangkok Sheet Metal Public Company Limited
BK:BM
|
0.047x |
|
Nath Bio-Genes (India) Limited
NSE:NATHBIOGEN
|
-0.160x |
|
Tikun Olam Cannbit Pharmaceuticals Ltd
TA:TKUN
|
0.221x |
|
Pico (Thailand) Public Company Limited
BK:PICO
|
-0.070x |
|
Aquaron Acquisition Corp. Common Stock
NASDAQ:AQU
|
-0.032x |
|
Xbrane Biopharma AB
ST:XBRANE
|
-0.009x |
Annual Cash Flow Conversion Efficiency for Nova EYE Medical Ltd (1992–2026)
The table below shows the annual cash flow conversion efficiency of Nova EYE Medical Ltd from 1992 to 2026. Review free cash flow generation of Nova EYE Medical Ltd to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2026-06-30 | AU$14.28 Million ≈ $10.10 Million |
AU$-3.12 Million ≈ $-2.21 Million |
-0.219x | +32.55% |
| 2025-06-30 | AU$18.97 Million ≈ $13.42 Million |
AU$-6.15 Million ≈ $-4.35 Million |
-0.324x | +11.97% |
| 2024-06-30 | AU$21.33 Million ≈ $15.09 Million |
AU$-7.86 Million ≈ $-5.56 Million |
-0.368x | -27.10% |
| 2023-06-30 | AU$23.19 Million ≈ $16.41 Million |
AU$-6.72 Million ≈ $-4.76 Million |
-0.290x | -88.11% |
| 2022-06-30 | AU$30.40 Million ≈ $21.51 Million |
AU$-4.68 Million ≈ $-3.31 Million |
-0.154x | +58.58% |
| 2021-06-30 | AU$35.34 Million ≈ $25.00 Million |
AU$-13.14 Million ≈ $-9.30 Million |
-0.372x | -786.28% |
| 2020-06-30 | AU$100.59 Million ≈ $71.17 Million |
AU$5.45 Million ≈ $3.86 Million |
0.054x | +188.64% |
| 2019-06-30 | AU$68.80 Million ≈ $48.68 Million |
AU$-4.21 Million ≈ $-2.98 Million |
-0.061x | -958.05% |
| 2018-06-30 | AU$73.24 Million ≈ $51.82 Million |
AU$522.00K ≈ $369.35K |
0.007x | +111.61% |
| 2017-06-30 | AU$56.93 Million ≈ $40.28 Million |
AU$-3.50 Million ≈ $-2.47 Million |
-0.061x | -156.81% |
| 2016-06-30 | AU$48.26 Million ≈ $34.14 Million |
AU$5.22 Million ≈ $3.69 Million |
0.108x | -37.57% |
| 2015-06-30 | AU$39.79 Million ≈ $28.16 Million |
AU$6.89 Million ≈ $4.88 Million |
0.173x | +136.60% |
| 2014-06-30 | AU$36.95 Million ≈ $26.14 Million |
AU$2.70 Million ≈ $1.91 Million |
0.073x | +16.05% |
| 2013-06-30 | AU$30.83 Million ≈ $21.81 Million |
AU$1.94 Million ≈ $1.38 Million |
0.063x | +10.04% |
| 2012-06-30 | AU$32.06 Million ≈ $22.68 Million |
AU$1.84 Million ≈ $1.30 Million |
0.057x | +777.54% |
| 2011-06-30 | AU$30.32 Million ≈ $21.45 Million |
AU$198.00K ≈ $140.10K |
0.007x | -95.38% |
| 2010-06-30 | AU$33.19 Million ≈ $23.48 Million |
AU$4.69 Million ≈ $3.32 Million |
0.141x | +6.79% |
| 2009-06-30 | AU$30.05 Million ≈ $21.26 Million |
AU$3.98 Million ≈ $2.81 Million |
0.132x | +633.47% |
| 2008-06-30 | AU$47.94 Million ≈ $33.92 Million |
AU$-1.19 Million ≈ $-841.29K |
-0.025x | -155.72% |
| 2007-06-30 | AU$43.38 Million ≈ $30.69 Million |
AU$1.93 Million ≈ $1.37 Million |
0.045x | +79.61% |
| 2006-06-30 | AU$35.14 Million ≈ $24.87 Million |
AU$871.00K ≈ $616.29K |
0.025x | +124.26% |
| 2005-06-30 | AU$28.99 Million ≈ $20.51 Million |
AU$-2.96 Million ≈ $-2.10 Million |
-0.102x | -358.55% |
| 2004-06-30 | AU$30.48 Million ≈ $21.57 Million |
AU$1.20 Million ≈ $851.91K |
0.040x | -55.72% |
| 2003-06-30 | AU$30.59 Million ≈ $21.64 Million |
AU$2.73 Million ≈ $1.93 Million |
0.089x | +370.50% |
| 2002-06-30 | AU$30.81 Million ≈ $21.80 Million |
AU$-1.02 Million ≈ $-718.88K |
-0.033x | +94.34% |
| 2001-06-30 | AU$789.86K ≈ $558.88K |
AU$-460.00K ≈ $-325.48K |
-0.582x | -305.46% |
| 1997-06-30 | AU$1.64 Million ≈ $1.16 Million |
AU$-235.77K ≈ $-166.82K |
-0.144x | -8.88% |
| 1996-06-30 | AU$1.72 Million ≈ $1.21 Million |
AU$-226.28K ≈ $-160.11K |
-0.132x | -91.37% |
| 1995-06-30 | AU$1.20 Million ≈ $851.91K |
AU$-83.00K ≈ $-58.73K |
-0.069x | +84.18% |
| 1994-06-30 | AU$280.00K ≈ $198.12K |
AU$-122.00K ≈ $-86.32K |
-0.436x | +28.94% |
| 1993-06-30 | AU$486.00K ≈ $343.88K |
AU$-298.00K ≈ $-210.85K |
-0.613x | -15.03% |
| 1992-06-30 | AU$741.00K ≈ $524.30K |
AU$-395.00K ≈ $-279.49K |
-0.533x | -- |
About Nova EYE Medical Ltd
Nova Eye Medical Limited designs, develops, manufactures, markets, and sells surgical devices for the treatment of glaucoma in Australia, the United States, Europe, the Asia Pacific, and internationally. The company operates through Glaucoma Surgical Devices and AlphaRET segments. It offers 2RT, a proprietary laser technology to treat patients in early and intermediate age-related macular degener… Read more